These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29248013)

  • 21. The significance of comprehensive staging surgery in malignant ovarian germ cell tumors.
    Liu Q; Ding X; Yang J; Cao D; Shen K; Lang J; Zhang G; Xin X; Xie X; Wu Y
    Gynecol Oncol; 2013 Dec; 131(3):551-4. PubMed ID: 24007946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jun; 145(3):513-518. PubMed ID: 28372870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germinal ovarian tumors in reproductive age women: Fertility-sparing and outcome.
    Dellino M; Silvestris E; Loizzi V; Paradiso A; Loiacono R; Minoia C; Daniele A; Cormio G
    Medicine (Baltimore); 2020 Sep; 99(39):e22146. PubMed ID: 32991408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
    Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
    J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
    Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
    Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.
    Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C
    Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery].
    Schröder W
    Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fertility sparing surgery in malignant ovarian Germ cell tumor (MOGCT): 15 years experiences.
    Zamani N; Rezaei Poor M; Ghasemian Dizajmehr S; Alizadeh S; Modares Gilani M
    BMC Womens Health; 2021 Aug; 21(1):282. PubMed ID: 34348686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fertility management for malignant ovarian germ cell tumors patients.
    Di Tucci C; Casorelli A; Morrocchi E; Palaia I; Muzii L; Panici PB
    Crit Rev Oncol Hematol; 2017 Dec; 120():34-42. PubMed ID: 29198336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant ovarian germ cell tumors: a single-institution experience.
    Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
    Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
    Xu W; Li Y
    Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of malignant ovarian germ cell tumors and preservation of fertility.
    Zhang R; Sun YC; Zhang GY; Wu LY; Zuo J
    Eur J Gynaecol Oncol; 2012; 33(5):489-92. PubMed ID: 23185794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproductive function assessment after surgery plus chemotherapy for germ cell ovarian tumors (MOGCT): novel clues deriving from the field of fertility preservation.
    Ottolina J; Mangili G; Sigismondi C; Vanni VS; Viganò P; Candiani M
    Gynecol Endocrinol; 2014 Nov; 30(11):778-80. PubMed ID: 25034573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Malignant ovarian germ cell tumors--clinical characteristics and analysis of outcomes].
    Miedzińska-Maciejewska M; Bobkiewicz P; Gawrychowski K
    Ginekol Pol; 2011 May; 82(5):338-43. PubMed ID: 21851031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.